lapachol has been researched along with Fatty Liver, Nonalcoholic in 1 studies
lapachol : A hydroxy-1,4-naphthoquinone that is 1,4-naphthoquinone substituted by hydroxy and 3-methylbut-2-en-1-yl groups at positions 2 and 3, respectively. It is a natural compound that exhibits antibacterial and anticancer properties, first isolated in 1882 from the bark of Tabebuia avellanedae.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study investigated the mechanism of action of lapachol (LAP) against non-alcoholic fatty liver disease (NAFLD)." | 8.31 | Lapachol treats non-alcoholic fatty liver disease by modulating the M1 polarization of Kupffer cells via PKM2. ( Kong, Y; Li, W; Sheng, J; Sheng, Y; Wang, J; Yang, Y; Zhou, X, 2023) |
| "This study investigated the mechanism of action of lapachol (LAP) against non-alcoholic fatty liver disease (NAFLD)." | 4.31 | Lapachol treats non-alcoholic fatty liver disease by modulating the M1 polarization of Kupffer cells via PKM2. ( Kong, Y; Li, W; Sheng, J; Sheng, Y; Wang, J; Yang, Y; Zhou, X, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yang, Y | 1 |
| Sheng, J | 1 |
| Sheng, Y | 1 |
| Wang, J | 1 |
| Zhou, X | 1 |
| Li, W | 1 |
| Kong, Y | 1 |
1 other study available for lapachol and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
Lapachol treats non-alcoholic fatty liver disease by modulating the M1 polarization of Kupffer cells via PKM2.
Topics: Animals; Diet, High-Fat; Kupffer Cells; Liver; Non-alcoholic Fatty Liver Disease; Rats; Rats, Spragu | 2023 |